Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elri Nortier
Observed name:
E. Nortier
Institution:
Stellenbosch University
Observed institution:
Stellenbosch University
ORCID:
0009-0009-7362-9962
Observed ORCID:
0009-0009-7362-9962
OpenAlex ID:
A5095891432
Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis
2025
·
Jennifer A Hughes
, Belén P Solans
, et al.
·
The Journal of Infectious Diseases
·
14
Acceptability of clofazimine capsules in children and adolescents with rifampicin-resistant TB
2024
·
D.T. Wademan
, Z. Saule
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
3
Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis
2026
·
Elri Nortier
, Milena M Boczar
, et al.
·
The Journal of Infectious Diseases
·
1
Presumed Levofloxacin-associated Lichenoid Drug Eruption in a Child With Rifampicin-resistant Tuberculosis
2024
·
Joh-Nell van der Westhuizen
, Mireille Porter
, et al.
·
The Pediatric Infectious Disease Journal
·
1
Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)
2026
·
Ingrid Courtney
, Meredith G Dixon
, et al.
·
JMIR Research Protocols
Show more works
View as search
Works count:
5
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type